Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

Final Recommendation Statement: Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer

The U.S. Preventive Services Task Force released today a final recommendation statement on aspirin use for the primary prevention of cardiovascular disease and colorectal cancer. Evidence shows that low-dose aspirin use is most beneficial for adults ages 50 to 59 years. Adults ages 60 to 69 years should decide with their primary care clinician if aspirin use for primary prevention is right for them. To view the recommendation and the evidence on which it is based, please go to http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer. A fact sheet that explains the final recommendation in plain language is also available on this page. The final recommendation statement can also be found in the April 12 online issue of Annals of Internal Medicine.

Current as of: December 2017

Internet Citation: Final Recommendation Statement: Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer. U.S. Preventive Services Task Force. April 2016.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/final-recommendation-statement-aspirin-use-for-the-primary-prevention-of-cardiovascular-disease-and-colorectal-cancer

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857